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Background: Glyoxalases are a varied group of enzymes that detoxify methylglyoxal by converting it to D-lactate.
Results: The Candida albicans glyoxalase Glx3 is important for yeast growth, especially in glycerol.
Conclusion:Many yeasts contain a novel group of glyoxalases that are not redundant with previously characterized enzymes.
Significance: This is the first demonstration of physiologically relevant glutathione-independent glyoxalases in fungi.
Methylglyoxal is a cytotoxic reactive carbonyl compoundpro-
duced by central metabolism. Dedicated glyoxalases convert
methylglyoxal to D-lactate using multiple catalytic strategies. In
this study, the DJ-1 superfamily member ORF 19.251/GLX3
from Candida albicans is shown to possess glyoxalase activity,
making this the first demonstrated glutathione-independent
glyoxalase in fungi. The crystal structure of Glx3p indicates that
the protein is a monomer containing the catalytic triad Cys136-
His137-Glu168. Purified Glx3p has an in vitro methylglyoxalase
activity (Km  5.5 mM and kcat  7.8 s1) that is significantly
greater than that of more distantly related members of the DJ-1
superfamily. A close Glx3p homolog from Saccharomyces
cerevisiae (YDR533C/Hsp31) also has glyoxalase activity, sug-
gesting that fungal members of the Hsp31 clade of the DJ-1
superfamily are all probable glutathione-independent glyox-
alases. A homozygous glx3 null mutant in C. albicans strain
SC5314 displays greater sensitivity to millimolar levels of exog-
enous methylglyoxal, elevated levels of intracellular methyl-
glyoxal, and carbon source-dependent growth defects, especially
when grown on glycerol. These phenotypic defects are comple-
mented by restoration of the wild-typeGLX3 locus. The growth
defect of Glx3-deficient cells in glycerol is also partially comple-
mentedby added inorganic phosphate,which is not observed for
wild-type or glucose-grown cells. Therefore, C. albicans Glx3
and its fungal homologs are physiologically relevant glutathi-
one-independent glyoxalases that are not redundant with the
previously characterized glutathione-dependent GLO1/GLO2
system. In addition to its role in detoxifying glyoxals, Glx3 and
its close homologs may have other important roles in stress
response.
Reactive carbonyl species are produced inmany organisms as
a consequence of central metabolism. Among these, methyl-
glyoxal (MG3;H3C–CO–CHO) has attracted considerable inter-
est dating from the early 20th century for its role as a branch
point metabolite for alternative catabolic pathways. MG is an
-ketoaldehyde metabolite produced principally by the spon-
taneous dephosphorylation of triose phosphates and, in some
prokaryotes, by the enzyme-catalyzed dephosphorylation of
dihydroxyacetone phosphate (DHAP) (1). A small fraction of
MG is also generated by catabolismof acetone and threonine (2,
3) and as a rare elimination side reaction of triose-phosphate
isomerase (4). In the model yeast Saccharomyces cerevisiae,
0.3% of all glycolytic carbon flux is converted to MG, making
it a potentially abundant metabolite under growth conditions
that favor high rates of glycolysis (5).
MG is cytotoxic at elevated concentrations because, as a
carbonyl electrophile, it can damage proteins, nucleic acids,
and lipids bymodification of arginine, lysine, cysteine, adenine,
and guanine to form various advanced glycation end products
(6, 7). Consequently, many organisms produce glyoxalases that
detoxify MG by converting it to D-lactate. These enzymes were
initially discovered in rabbit and dog tissues and first reported
100 years ago (8). Curiously for a toxic metabolite, MG is pro-
duced enzymatically from DHAP by a dedicated methylglyoxal
synthase in certain prokaryotes. In combinationwith the glyox-
alases, methylglyoxal synthase constitutes the initial portion of
the methylglyoxal bypass, which converts DHAP to MG, then
to D-lactate and, ultimately, to pyruvate (Fig. 1) (9). The meth-
ylglyoxal bypass has been proposed to serve an important cat-
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abolic role in phosphate-limited conditions, as it permits the
oxidation of DHAP to pyruvate without having carbon flux
through the more phosphate-demanding Embden-Meyerhof-
Parnas (EMP) glycolytic pathway (10).
In contrast to prokaryotes, eukaryotes do not possess a
clearly identified methylglyoxal synthase, and therefore MG
production from triose phosphates is presumed to be predom-
inantly nonenzymatic in these organisms (11). Enzymes such as
semicarbazide-sensitive amine oxidase can produce someMG,
although themagnitude of their contribution to totalMGpools
in eukaryotes is not clear (12). However, the absence of a known
methylglyoxal synthase does not necessarily mean that MG
serves no metabolic purpose in eukaryotes. Accumulation of
triose phosphates is inhibitory to glycolysis and can be partially
relieved by their spontaneous, nonenzymatic dephosphoryl-
ation to produce MG. Subsequent detoxification of MG by
glyoxalases could then facilitate a minor alternative pathway to
generate pyruvate and acetyl-CoA under nonoptimal growth
conditions when triose phosphates would otherwise accumu-
late to high levels. In contrast, under optimal growth condi-
tions, carbon flux is directed to the conventional EMP pathway
for pyruvate production.
Glyoxalases are required for the detoxification of MG and
may serve a metabolic role in producing D-lactate for further
catabolism. The best characterized glyoxalase is the glutathi-
one-dependent two enzyme system (glyoxylases I and II) that
detoxifies MG by converting it to D-lactate and regenerating
free glutathione. In this system, glutathione and MG are con-
verted to R-(S)-lactoylglutathione by the metalloenzyme
glyoxylase I (GLO1 in the yeasts) (13). The lactoylglutathione
product is then hydrolyzed by a second enzyme, glyoxylase II
(GLO2), to give D-lactate and glutathione (14). In addition to
the glutathione-dependent system, a less studied glutathione-
independent glyoxalase (glyoxalase III) in Escherichia coli can
catalyze the conversion ofMG to D-lactatewithout any cofactor
(Fig. 1). Although this activity was known to exist in lysates of
E. coli for many years (15), it was only recently ascribed to
Hsp31 (HchA), a previously characterized chaperone of the
DJ-1 superfamily (16). Consistent with its dual role in the
heat and carbonyl stress responses, transcription of E. coli
Hsp31/glyoxalase III is rpoS-dependent and thus highest in sta-
tionary phase (17, 18). An important lingering question is
whether the activity of glutathione-independent glyoxalases is
physiologically relevant, as it is unclear why this activity would
be needed in addition to the established glutathione-dependent
system for detoxifying glyoxals. Notably, both the glutathione-
dependent and -independent systems are present in many
organisms, including the model yeasts S. cerevisiae and Can-
FIGURE 1.A flowchart of central carbonmetabolism emphasizing the EMPpathway and two knownglyoxalase systems. The glutathione-independent
glyoxalase Glx3 is shown in the shaded box.HTA is the hemithioacetal adduct that spontaneously forms betweenMG and reduced glutathione, and SDLGSH is
the (RS)-lactoylglutathione product of glyoxalase I enzyme. The catalytic actions of glyoxalases are indicated with dashed lines.
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dida albicans, suggesting that they may not be functionally
redundant.
Investigating the physiological role of putative eukaryotic
glutathione-independent glyoxalases is aided by the abundance
of organisms that contain homologs from the Hsp31 clade of
the DJ-1 superfamily. S. cerevisiae is a natural choice for such a
study; however, S. cerevisiae contains four Hsp31 homologs
(YDR533C, YMR322C, YOR391C, and YPL280W), thus pre-
senting the challenge of generating knock-outs targeting mul-
tiple and very similar genes and then determining the degree of
functional redundancy among them (19, 20). Additionally, S.
cerevisiae switches from respiratory to fermentative metabo-
lism when presented with fermentable carbon sources such as
glucose in aerobic growth conditions (the Crabtree effect) and
can survive in fermentative growth conditions with nonfunc-
tional mitochondria (i.e. a “petite positive” yeast). Both of these
metabolic features act as serious confounding factors to the
study of endogenous MG toxicity as a function of carbon
source, as the entire metabolic program of the organism shifts
in a carbon source-dependent manner (21). In contrast, the
yeast C. albicans has only one Hsp31 homolog (ORF 19.251),
which simplifies the generation of knock-out strains and the
characterization of their phenotypes, thereby making C. albi-
cans a simpler model for studying the functions of these pro-
teins. Unlike S. cerevisiae,C. albicans respires in aerobic growth
conditions regardless of carbon source (i.e. it is a Crabtree
negative yeast) and therefore must retain functional mito-
chondria, making it a “petite-negative” yeast as well (21).
These metabolic features can be used to alter the level of
endogenously produced MG in C. albicans by growing the
cells in carbon sources whose catabolism produces different
levels of triose phosphates, the direct precursors to MG.
Because C. albicans is a Crabtree negative yeast, it will not
switch between respiratory and fermentative metabolic pro-
grams as a consequence of changing carbon sources, thus
eliminating a complication of using Crabtree positive yeasts
such as S. cerevisiae in this study.
In this study, theC. albicansYDR533C/Hsp31 homologORF
19.251 is shown to possess glutathione-independent glyoxalase
III activity. As a consequence, we propose that this gene be
named GLX3. Unlike the homologous proteins from S. cerevi-
siae and E. coli, the crystal structure of CaGlx3 indicates that it
is a monomer. As expected, the protein possesses a Cys-His-
Glu catalytic triad found in other members of the Hsp31 clade.
A combination of site-directedmutagenesis and enzyme kinet-
ics indicates that the active site cysteine residue is critical for
glyoxalase activity and that a nearby histidine residue is also
important. The in vivo relevance of glyoxalase III activity was
established by generating a glx3 knock-out mutant of C. albi-
cans and testing complementation with the wild-type allele.
The homozygous glx3 knockout was significantly more sensi-
tive to both exogenously administered MG and to MG pro-
duced endogenously by glucose or glycerol catabolism, espe-
cially when grown in glycerol. A rationale for the existence and
physiological significance of glutathione-independent glyox-
alases in fungi is discussed.
EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Growth Conditions—C. albicans
wild-type clinical isolate SC5314 was the generous gift of Dr.
Alexander Johnson, University of California at San Francisco.
C. albicans strains were grown andmaintained in yeast extract/
peptone/dextrose (YPD) medium (10 g of yeast extract, 5 g of
peptone, and 20 g of glucose per liter) at 30 °C. Growth curves
were measured in YPD that had been inoculated with cells
washed three times in 50mM potassium phosphate, pH 6.5, at a
density of 1  107 cells/ml. Cells were grown aerobically in
250-ml Erlenmeyer flasks containing 50 ml of media that were
incubated at 30 °C with 225 rpm rotary agitation. For determi-
nation of the role of Glx3p in C. albicansmetabolism, multiple
media were used as follows: YPD medium supplemented with
0–40 mM methylglyoxal, YPG (yeast extract/peptone medium
containing 2% v/v of glycerol), and YP (yeast extract/peptone
mediumcontaining neither glucose nor glycerol). All experiments
were done in triplicate andmeans S.D. were calculated.
Cloning and Purification of Glx3—The gene encoding Glx3
(ORF19.251) was PCR-amplified from C. albicans SC5314
genomic DNA using primers (Table 1) that introduced 5-NdeI
and 3-XhoI restriction sites. The PCR product was purified,
digested with NdeI and XhoI, and cloned between the corre-
sponding restriction sites of the bacterial protein expression
vector pET15b (Novagen). The C136S and H137F point muta-
tions were introduced using site-directed mutagenesis, and all
constructs were verified using DNA sequencing (Operon).
E. coli strain BL21 (DE3) (Novagen) was transformed with
GLX3-pET15b and grown at 37 °C in terrific broth medium
supplemented with 100 g/ml ampicillin and with shaking at
270 rpm to an OD6002.0. Expression of Glx3 was induced by
the addition of isopropyl -D-1-thiogalactopyranoside (Sigma)
to a final concentration of 1 mM for 18 h at 25 °C. Two hours
TABLE 1
Primers used in this study
Sequence Name Reference Purpose
5-TCC GAG GGG GGT ACC TCC TTC-3 KpnI This study Glx3 knockout
5-TTG AAA CAC TCG AGG AAG GGG-3 XhoI This study Glx3 knockout
5-GGG CAT ACA AAA GCC GCG GAT TTA-3 SacI This study Glx3 knockout
5-AAC AAA ATT AAT TGA GCT CTC TTG-3 SacII This study Glx3 knockout
5-TAT TGT TGA TGA ATC GAA GAA AAC-3 Upstream check This study Southern blot
5-TGT TTA GTA GAT CTT TCT AGA TCT-3 Downstream check This study Southern blot
5-TAA AAA TAT CAT ATG GTG AAA GTT TTA CTC-3 NdeI This study Glx3 insertion in pET15b
5-TAA TTT CTC GAG TTA ATT ACA TTC AAA AGG-3 XhoI This study Glx3 insertion in pET15b
5-CTT TCT GCT GTT AGT CAT GGT CCT GCC AT-3 Forward C136S This study Glx3 (C136S) point mutation
5-ATG GCA GGA CCA TAA ACA GCA GAA AC-3 Reverse C136S This study Glx3 (C136S) point mutation
5-GTT TGT TTT GGT CCT GCC ATT TTT-3 Forward H137F This study Glx3 (H137F) point mutation
5-AAA AAT GGC AGG ACC AAA ACA AAC-3 Reverse H137F This study Glx3 (H137F) point mutation
Structure and Function of Candida albicans Glyoxalase III
1664 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 3•JANUARY 17, 2014
 
 
before harvesting the cells, chloramphenicol was added to the
culture to a final concentration of 100 g/ml to arrest protein
synthesis and enhance the solubility of the expressed protein
(22). The cells were harvested by centrifugation at 4 °C and then
resuspended in ice-cold lysis buffer (50mMHEPES, pH 7.5, 300
mMNaCl, and 10mM imidazole, 1mMDTT) at a ratio of 5ml of
buffer per g of wet cell mass. Cells were lysed by the addition of
lysozyme to a final concentration of 1mg/ml and incubation for
30 min, followed by sonication. The lysate was clarified by cen-
trifugation at 12,000 g to remove cellular debris.
Cleared lysate was mixed with His-Select Ni2metal affinity
resin (Sigma) for 30 min with gentle stirring at 4 °C. The resin
was transferred to a glass column and washed extensively with
wash buffer (25mMHEPES, pH 7.5, 300mMNaCl, 20mM imid-
azole, 2mMDTT) until no protein was detected in the eluate by
Bradford’s reagent (Bio-Rad). N-terminal hexahistidine-tagged
Glx3 was eluted from the resin with ice-cold elution buffer (25
mM HEPES, pH 7.5, 300 mM NaCl, 200 mM imidazole, 2 mM
DTT) and then incubated with bovine thrombin (MP Biomedi-
cals) at a ratio of 1.5 units of thrombin/mg of Glx3 for 3 h at
room temperature, followed by overnight dialysis against stor-
age buffer (25mMHEPES, pH7.5, 100mMKCl, and 2mMDTT).
After digestion, any protein retaining the histidine tag was sep-
arated from the tag-cleaved protein by a second passage over
His-select resin that had been equilibrated in storage buffer.
The flowthrough fractions, containing purified tag-cleaved
protein Glx3, were then passed over benzamidine-Sepharose
(Amersham Biosciences) resin to remove thrombin. Unexpect-
edly, a considerable amount of Glx3 binds to benzamidine-Sep-
harose under these conditions. The purified protein was con-
centrated using a stirred cell concentrator with a nominal
molecular mass cutoff of 10 kDa to 20 mg/ml, as determined
using UV-visible spectrophotometry with a calculated extinc-
tion coefficient at 280 nm (280) of 21,555 M1 cm1 for Glx3
(ExPASy). The purified protein ran as a single band onCoomas-
sie Blue-stained SDS-PAGE and was aliquoted into 50–100-l
volumes, flash-frozen in liquid nitrogen, and stored at 80 °C
until needed.
Crystal Structure Determination of Glx3—Glx3 (20mg/ml in
storage buffer) was crystallized using sitting drop vapor equili-
bration. Initial crystallization conditionswere identified using a
96-well plate and commercially available sparse matrix crystal-
lization screens. Conditions delivering crystals were further
optimized by fine screening using sitting drop vapor equilibra-
tion of drops containing 2 l of Glx3 with 2 l of reservoir
solution. Obelisk-shaped crystals of wild-type Glx3 measuring
20 20 100mgrew from100mM sodium acetate, pH 4.1,
120 mM ammonium acetate, 27% PEG4000, and 3% ethylene
glycol at 4 °C after 1–3 days. The crystals were cryoprotected by
serial transfer through reservoir solution supplemented with
increasing concentrations of ethylene glycol to a final concen-
tration of 20% v/v. Crystals were removed with nylon loops and
cryocooled by rapid immersion into liquid nitrogen.
X-ray diffraction data were collected from a single crystal
maintained at 100 K at SSRL beamline 9-2 using 13.79 keV
incident x-rays and a MarMosaic 325 charge coupled device
detector. The crystal was exposed to x-rays during 0.5° oscilla-
tions, and 300 images were collected and processed. The data
were indexed, integrated, and scaled using HKL2000 (23), and
final data statistics are shown in Table 2.
Phases and an initial model for Glx3 were obtained using
maximum likelihood molecular replacement in PHASER (24),
part of the CCP4 suite of programs (25). A homology model
based on the coordinates of one monomer (chain A) of
YDR533C (PDB code 1RW7) (20) was generated by Swiss-
Model (26) andused for the rotation and translation searches. A
clear top solution was obtained, which was then subjected to
stereochemically restrained refinement with riding hydrogen
atoms against an amplitude-based maximum likelihood target
in REFMAC5 (27). All measured data were used for the refine-
ment, and a bulk solvent correction was applied. The transla-
tion-libration-screw model was used for refinement of aniso-
tropic atomic displacement parameters based on a rigid body
displacement model that treated the entire protein as a single
rigid group (28, 29). Ordered solvent placement and manual
adjustments to the model were performed in COOT (30), and
the final model was validated using the validation tools in
COOT (30) and MOLPROBITY (31). All structural figures
were made with UCSF Chimera (32).
Glutathione-independent Glyoxalase Assay—Glyoxalase activ-
ity was assayed in vitro using a previously described fixed time
point assay that follows the enzymatic depletion of the substrate
methylglyoxal (33). Methylglyoxal (Sigma, 40% solution) is
unstable and was thus stored at 4 °C until immediately before
use. The reaction was initiated by adding enzyme in reaction
buffer (100 mM HEPES, pH 7.5, 50 mM KCl, 2 mM DTT) to the
specified initial concentration of methylglyoxal in reaction
buffer, followed by incubation at 30 °C. The final enzyme con-
TABLE 2
Crystallographic data collection and refinement statistics
Data collection
X-ray source SSRL 9-2
X-ray wavelength 0.90 Å
Space group P42212
Cell dimensions
a b, c 92.23 Å, 59.37 Å
   90°
Molecules in asymmetric units 1
Wilson B factor 21 Å2
Resolutiona 41 to 1.6 Å
No. of reflections 34,216
Completeness 100.0% (100.0%)
Redundancy 12.1 (12.2)
Rmergeb 0.05 (1.00)
	I
/	(I)
 51.1 (2.2)
Refinement
Resolution 41 to 1.6 Å
Rworkc; Rfreed; Ralle 15.8%; 18.5%; 15.9%
No. of protein atoms 1843
No. of solvent atoms 279
No. of heteroatoms 8
Root mean square deviations
Bond lengths 0.006 Å
Bond angles 1.08°
Ramachandran plot favored; allowed; forbidden 97%; 100%; 0%
a Values in parentheses are for highest resolution shell (1.63 to 1.60 Å).
bRmerge hkliIhkli  	Ihkl
/hkliIhkli , where i is the ith observation of a reflec-
tion with indices h,k,l, and angle brackets indicate the average over all i
observations.
c Rwork hklFhklo  Fhklc / Fhklo , where Fhklc is the calculated structure factor am-
plitude with index h,k,l, and Fhklo is the observed structure factor amplitude with
index h,k,l.
dRfree is calculated as Rwork, where the Fhklo are taken from a test set comprising 5%
of the data (1730 reflections) that were excluded from the refinement.
e Rall is calculated as Rwork, where the Fhklo includes all measured data (including
the Rfree test set).
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centration was 10 M. The methylglyoxal remaining at each
time point was determined by reaction with 2,4-dinitrophenyl-
hydrazine (DNPH) to generate the purple chromophore
methylglyoxal-bis-2, 4-dinitrophenylhydrazone after alkali
treatment. As this was a substrate depletion assay, a rela-
tively high concentration of enzyme (10 M) was used to
observe clear differences in remaining substrate concentra-
tion over the first 1–2 min of reaction. In all cases, however,
substrate was saturating at 10-fold excess, justifying the
steady-state assumption.
The assay was performed by removing a 50-l sample of the
reaction at fixed timepoints after enzyme addition (0, 15, 30, 45,
60, and 75 s) and rapidly mixing with 0.9 ml of distilled water.
To this solution, 0.33 ml of a freshly prepared stock of DNPH
reagent (0.2% DNPH dissolved in 2 N HCl) was immediately
added and incubated at 30 °C for 15 min. This highly acidic
solution stops the enzymatic reaction, whose rate was already
greatly diminished by the initial 19-fold dilution intowater. The
characteristic purple color of the hydrazone was developed by
addition of 1.67ml of 3.8 MNaOH and incubation for 5–10min
at room temperature followed by measurement of absorbance
at 550 nm in a SpectraMax Plus spectrophotometer (Molecular
Devices). All measurements were made in triplicate and multi-
ple preparations of Glx3 were assayed to verify consistent levels
of activity. The measured absorbance values at 550 nm were
converted to concentration of methylglyoxal using interpola-
tion onto the best-fit line for a methylglyoxal-DNPH calibra-
tion curve. The rate of spontaneous loss of MG in solution,
determined as above but without added enzyme, wasmeasured
and subtracted from all enzymatic rates. Steady-state enzy-
matic parameters were obtained by fitting the Michaelis-Men-
ten model to the data using Prism (GraphPad).
The glyoxalase assay based on methylglyoxal depletion was
complemented by an assay based on the formation of D-lactic
acid. As above, 50-l samples were taken from buffered 10 M
enzyme with varying initial concentrations of methylglyoxal at
30-s increments for the first 150 s of the reaction. These sam-
ples were heat-inactivated at 80 °C for 30 s, cooled, supple-
mented with 10 mM NAD, and 1 unit of D-lactate dehydroge-
nase (Sigma catalog no. L-3888 from Lactobacillus leichmanii),
and incubated for 30min at 37 °C. D-Lactate dehydrogenasewill
oxidize any D-lactate that was produced by glyoxalase activity,
producing pyruvate andNADH. The absorbance of NADHwas
measured at 340 nm and converted to a molar concentration
using an extinction coefficient at 340 nm of 6220 M1 cm1.
Specific Activity Measurements—Initial rates of methyl-
glyoxal depletion or D-lactate production were measured as
described abovewith 10Menzyme acting on 6mM substrate at
both 30 °C (methylglyoxal consumption) and at 37 °C (D-lactate
production). These initial rates were divided by the amount of
enzyme in the reaction to calculate the reported specific activ-
ities, and all measurements were made in triplicate. Means 
S.D. for triplicate measurements are reported in Table 3.
Generation of the glx3NullMutant—Theupstream fragment
of glx3was amplified by PCR using primers introducing a distal
restriction site for KpnI and a proximal site for XhoI (Table 1).
A downstream fragment of the genewas amplifiedwith primers
that introduced a proximal SacII and a distal SacI restriction
site (Table 1). The fragments were cloned into the pSFS2A vec-
tor at positions up- and downstream of a SAT1 flipper cassette,
creating the construct pSFS2A-GLX3-flank. This SAT1 flipper
cassette contains a nourseothricin marker (caSAT1) and an
adapted FLP gene (CaFLP) encoding a site-specific recombi-
nase under the control of C. albicans MAL2 promoter (34). A
linear fragment containing the disruption cassette was created
by digesting the pSFS2A-GLX3-flank construct with KpnI and
SacI. The fragment was purified by agarose gel electrophoresis
followed by gel extraction of the excised target band (Qiagen).
The fragment was introduced by electroporation into C. albi-
cans according to the procedure described in Reuss et al. (34).
Briefly, 1g of linearDNAwasmixedwith 40l of electrocom-
petent SC5314 cells and subjected to electroporation (0.2-cm
cuvette, 1.5 kV, 400 ohms). The cells were incubated with a 1:1
ratio of 1 M sorbitol/YPD at 30 °C for 2 h with shaking at 225
rpm followed by spreading onto a YPD plate containing 200
g/ml nourseothricin, which was incubated at 30 °C overnight.
The following day, the resistant colonies were picked and
streaked again onto a YPD plate containing 200 g/ml
nourseothricin. Resistant cells were analyzed for the first allelic
replacement by PCR and Southern blotting (primers, see Table
1). After confirming that one of the GLX3 alleles had been
replaced with the caSAT1 cassette (glx3-a1), the cells were
inoculated into YPM liquidmedium (10 g of yeast extract, 5 g of
peptone, and 20 g of maltose per liter) without selective pres-
sure to allowFLP-mediated excision of the cassette as described
by Reuss et al. (34). After 6 h of incubation at 30 °C, serially
diluted cells were spread on a YPD plate containing 25 g/ml
nourseothricin to assay for restoration of antibiotic sensitivity
resulting from FLP-mediated excision of CaSAT1 (glx3-a2).
These cells were used for the second allelic deletion following
the same procedure.
Measurement of Intracellular Methylglyoxal Concentration—
Cellular MG concentrations were measured using a modifica-
tion of the procedure described by Scheijen and Schalkwijk (35)
TABLE 3
Comparative glyoxalase-specific activities of selected DJ-1 superfamily proteins
Human
DJ-1
Sz. pombe
DJ-1
S. cerevisiae
YDR533C
C. albicans
Glx3
C. albicans
C136S Glx3
C. albicans
H137F Glx3
Methylglyoxal consumption
(mol/min/mg enzyme)
1.0 0.3a 2.4 0.2 6.4 0.1 11.5 0.1 0.2 0.1b 1.7 0.1
D-Lactate production
(mol/min/mg enzyme)
NDc ND 10.5 1.0 7.0 1.0 ND ND
a Values shown are the average of triplicate experiments S.D. using purified proteins as expressed in E. coli. The methylglyoxal assay was performed at 30 °C and the D-lac-
tate assay at 37 °C.
b This value is near the noise level of the measurement and is consistent with no significant activity.
c Data not detected with an estimated detection limit of0.2 mol/min/mg enzyme for NADH production.
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and McLellan et al. (36). Late log phase cells were harvested
from liquid culture by centrifugation and immediately frozen at
80 °C. Cell pellets were resuspended in buffer containing 0.3
M sucrose, 10 mM histidine, and 0.23 mM phenylmethylsulfonyl
fluoride, pH 7.4 (2 l of buffer per mg of pellet). Cell suspen-
sions were then sonicated three times for 5 s (setting 4, Fisher
M100 sonicator) within 15-s intervals. Thereafter, the soni-
cated samples were added to equal volumes of 5.0 M perchloric
acid and placed on ice for 10 min. Samples were then centri-
fuged for 10 min at 3000 rpm (Eppendorf 5417R, EL 129 FA
45-24-11 rotor). Supernatants (50l) were thenmixedwith 150
l of 0.1 M o-phenylenediamine in 1.6 M perchloric acid and
allowed to react for 16 h at room temperature in the dark. After
this reaction,mixtureswere extracted three timeswith 2.0ml of
chloroform, and pooled extracts from each sample were dried
over anhydrous sodium sulfate. Chloroform was then evapo-
rated from each sample using a gentle stream of air, and samples
were resuspended in 500l ofmethanol.Highperformance liquid
chromatography (SCL-Shimadzu 10A) employing a Kinetex
5-m C18 100R column, a mobile phase of methanol/water/
trifluoroacetic acid (52:48:0.1) at a flow rate of 1 ml/min, and a
detectorwavelength of 312 nmwere then used to determine the
amount of 2-methylquinoxaline, the product formed following
the reaction of MG and o-phenylenediamine. For these exper-
iments 2-methylquinoxaline concentrations ranging from 1 to
100 M were used to generate the standard curve for absolute
concentration determination.
RESULTS
Crystal Structure of C. albicans Glx3p—The crystal structure
of Glx3p was determined at 1.6 Å resolution using molecular
replacement with a homology model based on S. cerevisiae
YDR533C (PDB code 1RW7) (20). Glx3 contains the standard
DJ-1 superfamily flavodoxin-like core foldwith several noncon-
tiguous secondary structural elements (helices B, H, and I and
strands 2 and 3) that form a “cap” region that has been previ-
ously called the P domain in other homologs of Hsp31 (Fig. 2A)
(20, 37). The structure is very similar to that of YDR533C (core
C root mean squared deviation  0.81 Å), as expected based
on their 62% sequence identity.
All other structurally characterized members of the Hsp31
clade, including E. coliHsp31 (PDB code 1N57) (37) and the S.
cerevisiae proteins YDR533C (PDB code 1RW7) (20) and
Y0R391C (PDB code 3MII) (38), are homodimers. Although all
previously characterized Hsp31-like proteins are dimeric,
E. coli Hsp31 contains a 45-amino acid N-terminal extension
that results in a formation of a different dimer than observed for
the yeast proteins YDR533C or YOR391C, which lack this
extension (20, 37–41). This N-terminal 45-amino acid region
has been shown to be important for chaperone activity of the
E. coli Hsp31 (42, 43), and its absence in YDR533C indicates a
potential functional difference between these proteins. The
structure of C. albicans Glx3 also lacks this 45-amino acid
N-terminal extension but, unlike YDR533C and YOR391C, is a
monomer in the crystal. The best candidate for a potential
dimer interface buries 606 Å2 of surface area per monomer as
calculated by PISA (44). However, this interface features a clus-
ter of acidic residues (Glu13, Glu48, and Asp117) in which Glu13
makes a short hydrogen bond (2.44 Å) with Glu48 from the
other monomer, requiring at least one of the side chains to be
protonated as a carboxylic acid (Fig. 2B). Crystals of Glx3 could
only be obtained at pH values below 4.1, suggesting that the
protonation of these carboxylic acids is essential to crystallize
Glx3 in this lattice. Because this lattice contact involves multi-
ple carboxylate side chains that would likely be negatively
charged at physiological pH, this intermolecular interface is
likely not physiologically relevant.
The active site for C. albicans Glx3 contains the triad resi-
dues Cys136, His137, andGlu168, as well as nearby residues Glu28
FIGURE 2. C. albicans Glx3 is a monomeric member of the Hsp31 clade of
the DJ-1 superfamily. A, ribbon diagram of Glx3 is shown with -strands
numbered and in red and -helices lettered in blue. The N and C termini are
labeled. Active site residues are shown in bond representation. B shows a
close-upview lattice contract that represents the largest intermolecular inter-
face between Glx3 proteins in the crystal. The two proteins are colored pale
blue and gold, with primes on residues from the other chain. 2mFo  DFc
electron density is shown contoured at 1 and colored blue. The carboxylic
acid-rich contact regionbetween twoproteins and the close2.44-Åhydrogen
bond between Glu13 and Glu48 requires low pH to be stable and would not
form under physiological conditions. Therefore, there are no intermolecular
contacts of probable physiological relevance in the Glx3 crystal.
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and His106 (Figs. 2A and 3A). These residues are conserved in
Hsp31 proteins from yeast and bacteria, and theGlx3 active site
alignswell with that of theE. coli enzyme (Fig. 3B). The catalytic
Cys136 sits at the bottom of a narrow active site pocket that can
accommodate only small molecule substrates (Fig. 3C), consis-
tent with a role in detoxifying low molecular mass glyoxals. As
observed inmany other DJ-1 superfamily crystal structures (20,
45–49), the active site cysteine residue is surrounded by
unusual electron density indicative of probable partial oxida-
tion of the reactive thiol(ate). Twooxygen atoms aremodeled at
2.25 and 2.06 Å from the S atom of Cys136 (Fig. 3A). These
distances are shorter than the van der Waals contact distances
expected for these atoms (3.3 Å) but too long to be fully
formed covalent bonds, similar to a previous observation in a
crystal structure of human DJ-1 (50). Although the cysteine
residue of human DJ-1 and its close homologs are easily oxi-
dized to cysteine sulfinic acid (51), the electron density for
Cys136 in Glx3 is not completely consistent with this covalent
modification. Therefore, these two oxygen atoms were conser-
vatively modeled as water molecules in the crystal structure.
We speculate that photoreduction and subsequent redox
chemistry caused by synchrotron radiation may be responsible
for this modification, as noted previously in Pseudomonas fluo-
rescens isocyanide hydratase (46). In total, the structural fea-
tures of the Glx3 active site are consistent with a hydrolase
employing a Cys-His-Glu catalytic triadwith a reactive cysteine
that attacks small electrophilic substrates.
Glx3 Has Glutathione-independent Glyoxalase Activity in
Vitro—The in vitro glyoxalase activity of C. albicans Glx3 was
assayed using a fixed time point assay that follows the depletion
of the substrate methylglyoxal as detected by formation of the
purple-colored methylglyoxal-bis-2,4-dinitrophenylhydrazone
adduct (see “Experimental Procedures”). Purified C. albicans
Glx3 possessed robust glyoxalase activity in vitro (Table 3), and
this activity was confirmed by a complementary assay based on
the appearance of D-lactate (Table 3). Glutathione was not
required for this activity, consistent with previous studies of
E. coli Hsp31 (16). The kinetic constants for C. albicans Glx3
(Km 5.5 mM, kcat 7.8 s1 (see Fig. 4)) are comparable with
those reported for E. coliHsp31 (Km 1.43 mM, kcat 2.7 s1)
(16). A notable structural difference between the fungal and
prokaryotic enzymes is the more exposed active site in C. albi-
cans Glx3 that is partially occluded by an -helix in E. coli
Hsp31 (Fig. 3B). As expected, mutation of the proposed cata-
lytic nucleophile Cys136 to serine resulted in an inactive enzyme
(Table 3 and Fig. 4). Mutation of His137 to phenylalanine in the
catalytic triad gave 15% of wild-type activity (Table 3), sug-
gesting that His137 also plays an important role during catalysis.
Itmay serve as a general acid/base for one ormore of the proton
shuffling steps that are required to convert MG to lactate with-
out a change in redox state. A proposed mechanism for glyox-
alase III enzymatic activity is presented under “Discussion.”
Methylglyoxalase Activity Is Common to Yeast Members of
the Hsp31 Clade—Three recombinant yeast enzymes exhibited
significant glyoxalase activity (Table 3), whereas under our
assay conditions, we could detect only very weak glyoxalase
activity for recombinant human DJ-1 (Table 3). The S. cerevi-
siae protein YDR533C had a comparable specific activity for
FIGURE 3. Glx3 contains a Glu-His-Cys catalytic triad at the bottom of a
narrow active site cleft. A, catalytic triad and surrounding residues of the
Glx3 active site are shown, with 2mFoDFc electron density contoured at 1
and shown in blue. Hydrogen bonds are indicated with dashed lines, and
ordered water molecules are represented as red spheres. The Glu168-His137-
Cys136 triad is surrounded by the other highly conserved residues His106 and
Glu28, and these residues may serve as general acids/bases. B, comparison of
CaGlx3 (gold) and E. coli Hsp31 (purple) shows that the EcHsp31 active site is
somewhat more occluded by an additional -helix. This may be responsible
for the lower reported kcat value of EcHsp31 comparedwithCaGlx3.C, surface
of CaGlx3 is shown with the location of the catalytically essential Cys136 indi-
cated in yellow. The narrow6-Å opening of this active site is selective for small
substrates such as MG.
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bothMG consumption and D-lactate production to C. albicans
Glx3 (Table 3), reflecting the aforementioned structural simi-
larities of these two members of the Hsp31 clade of the DJ-1
superfamily. Interestingly, significant consumption of MG was
also measured for Sz. pombeDJ-1 (SPAC22E12.03c), which is a
close homolog of human DJ-1 and not a member of the Hsp31
clade (52, 53). However, unlike C. albicans Glx3 and S. cerevi-
siae YDR533C, no D-lactate production was detected for the
human or Schizosaccharomyces pombe enzymes, suggesting
either that another product is generated or that the D-lactate
assay was not sensitive enough to detect the small quantity of
product formed. The physiological relevance of the glyoxalase
activities of the human and Sz. pombe proteins are therefore
unclear. The Hsp31-like yeast proteins CaGlx3 and ScHsp31/
YDR533C, in contrast, have robust glyoxalase activities and
produce the expected D-lactate product, suggesting conserva-
tion of function for this clade of the DJ-1 superfamily.
Glx3 Confers Protection against Both Exogenous and Endog-
enously Generated Methylglyoxal—C. albicans is a diploid
organism, and consequently the biological significance of Glx3
must be assessed via a double knock-out mutant. The double
knock-out (glx3-1/glx3-1) and reconstituted strains were
created by standard procedures (34), confirmed by Southern
blots (Fig. 5), and then tested for their respective sensitivities to
exogenous MG in yeast extract/peptone  2% glucose (YPD)
medium under aerobic culture conditions. The glx3-1/
glx3-1mutant wasmore sensitive to 20 and 40mM exogenous
MG than was its wild-type parent (Fig. 6). In contrast, 10 mM
MG had no effect on the growth of any strain (Fig. 6). This
experiment establishes that Glx3 can detoxifyMG in vivo; how-
ever, we note that the high levels of exogenous MG used here
are of uncertain physiological relevance.
Endogenous MG is generated as an unavoidable conse-
quence of central carbon metabolism and was modulated by
altering the carbon source provided to cultured C. albicans.Of
the commonly used carbon sources in media, glycerol has been
shown to produce the highest levels of triose phosphates, the
immediate precursors to MG (54). The metabolic defects
caused by Glx3 deficiency are evident when cell yields obtained
by growth in yeast extract/peptone (YP), yeast extract/peptone/
glucose (YPD), and yeast extract/peptone/glycerol (YPG)
media are compared (Fig. 7). Note that following microbiolog-
ical convention, the OD600 values of all growth curves in Figs.
6–8 are plotted on logarithmic y axes. Both the wild-type and
Glx3-reconstituted (glx3-1/glx3-1/GLX3) C. albicans had
equivalent cell yields (OD600 10) on YPD and YPG but
achieved only OD600  3.5 on YP alone. Thus, cells that
expressed Glx3 used glucose and glycerol equivalently, result-
ing in an2.5-fold increased yield compared with YP alone. In
contrast, the glx3-1/glx3-1 mutant had markedly reduced
OD600 values of 7 and 2.5 on YPD and YPG media, respec-
FIGURE 4. Glx3 is a glutathione-independent methylglyoxalase. The
kinetics ofwild-typeGlx3 (filled circles) and theC136Smutant (open circles) are
shown inhyperbolic representation, and thebest fitMichaelis-Mentenmodel
is indicated with a solid line. Each rate was measured in triplicate, and mean
values are plotted with standard deviations shown as error bars. At each con-
centration, the background uncatalyzed rate of MG degradation was mea-
sured and subtracted from the ratemeasuredwith enzymepresent. The inac-
tive C136S mutant demonstrates that the proposed catalytic nucleophile
Cys136 is essential for catalysis.
FIGURE 5. Southernblot analysis of theGLX3gene inC. albicans.Genomic
DNA from parental (1st lane), reconstituted (2nd lane), and the glx3-1/
glx3-1 null mutant (3rd lane) was digested with XbaI, blotted, and probed
with a 1623-bp fragment covering the GLX3 gene. -Actin was used as the
loading control.
FIGURE 6. Glx3 is protective against exogenously added methylglyoxal.
Cultures were grown aerobically in yeast extract/peptone  2% glucose
(YPD) medium at 30 °C with increasing methylglyoxal concentrations (noted
on figure). The measured optical density is plotted on semi-log axes for C.
albicans SC5314 (A) and the glx3-1/glx3-1 homozygous deletion mutant
(B). Values shown are the average of triplicate experiments S.D.
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tively (Fig. 7). Cell yield in YPmediumwas not strongly affected
by the glx3 knockout. The 4-fold reduction in cell yield of the
glx3 null mutant grown in YPG is quite large and indicates that
the knock-out strain gains no metabolic benefit from the 2%
glycerol present in the medium and may even be somewhat
inhibited by it. The strong growth defect of the glx3 nullmutant
in YPG is likely connected to elevated endogenous MG levels
under these growth conditions, because glycerol elevates the
levels of triose phosphates in the cell and has been shown to
substantially increase the production of MG in S. cerevisiae
(54). Therefore, Glx3 plays an important role in central carbon
metabolism and cellular viability in C. albicans, particularly
when glycerol is the principal carbon source.
Because Glx3 has glyoxalase activity in vitro, we tested the
hypothesis that the observed growth defects of the knockout
are due to elevated levels of endogenously produced MG. The
levels of intracellular MG in late log phase cells were directly
measured using the chemical capture ofMG by o-phenylenedi-
amine to form the UV-absorbing compound 2-methylquinoxa-
line that was monitored by HPLC (see “Experimental Proce-
dures”). This quantitative method is highly selective for the
target -oxoaldehydes and is more efficient that previous
approaches, which are important advantages when measure-
ments are being made in the cellular milieu (35). Greater than
95% of the MG in solution reacted with o-phenylenediamine,
and chloroform extraction recovered 96% of 2-methylqui-
noxaline from solution. The results are shown in Table 4. As
expected, wild-type cells produced more endogenous MG in
media containing glycerol (YPG) than in media containing glu-
cose (YPD). Cells grown in media lacking either carbon source
(YP) have an unexpectedly high level of MG, which is compa-
rable with that of cells grown in YPDmedium. The importance
of Glx3 for detoxification of endogenously produced MG is
shown by the 3–5-fold increase in levels of intracellular MG in
glx3-1/glx3-1 cells grown in YPD or YPG media compared
with wild-type cells grown in the same media. Re-introduction
of theGLX3 gene into the knock-out strain restored intracellu-
lar MG concentrations to levels that are slightly below those of
wild-type cells grown in either YPD or YPGmedia, confirming
that elevated MG in the knock-out strain is due to the absence
of Glx3. In contrast, MG levels in glx3-1/glx3-1 cells grown
in YP are elevated and not reduced to base-line levels by resto-
ration of GLX3. This is a topic for future investigation. These
experiments allow for the simultaneous measurement of cellu-
lar glyoxal, a closely related -oxoaldehyde. Glyoxal levels were
unaffected by the presence or absence of Glx3 in all media,
indicating that the enzyme is selective for MG as a substrate in
vivo.
Phosphate Supplementation Partially Complements the
Growth Defect of Glx3 Null Cells in Glycerol—Inorganic phos-
phate (orthophosphate) plays a key role in the metabolism of
triose phosphate sugars, and phosphate-rich trioses accumu-
late when yeasts are grown on glycerol as a carbon source (54).
Adding 10 mM of supplemental potassium phosphate to the
growth medium had no effect on the cell yields for wild-type C.
albicans under any condition (Fig. 8, A–C) and only a slightly
FIGURE 7. Glx3 protects against endogenous MG generated by basal
catabolism. Cell yields for parental (filled circles), glx3 null mutants (open cir-
cles), and reconstituted (filled squares) C. albicans were measured by optical
density in multiple media and plotted on semi-log axes as a function of time.
A shows that all cell types grow comparably well on yeast extract/peptone
(YP) medium. B, glx3 null cells (glx3; open circles) show a marked growth
defect in YPD (YP 2% glucose) medium that is complemented by restora-
tion of the wild-type GLX3 locus (glx3/GLX3; filled squares). C, glx3 null cells
(glx3; open circles) showamorepronouncedgrowthdefect in YPG (YP 2%
glycerol) medium that is complemented by restoration of thewild-typeGLX3
locus (glx3/GLX3). YPGmedium is expected to produce the highest levels of
endogenous MG. Values shown are the average of triplicate experiments
S.D.
TABLE 4
Levels of intracellular methylglyoxal in C. albicans
The experiment was repeated in technical duplicate with replicate values differing
by less than 5% for all measurements.
Media
Cell type
Wild type Glx3 Glx3glx3
YPa 4.5b 13.1 12.3
YPD 4.5 24.9 1.3
YPG 13.8 49.5 12.8
a YP, yeast extract/peptone; YPD, yeast extract/peptone/dextrose; YPG, yeast
extract/peptone/glycerol.
b All units are in nanomoles of methylglyoxal/g wet cell weight.
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ameliorative effect for the glx3-1/glx3-1mutant in YPD (Fig.
8B), but it doubled the cell yield for the glx3 null mutant in YPG
(Fig. 8C). Because this additional inorganic phosphate has no
effect on the yields of the wild-type cells, we conclude that YP
medium is not limited in total phosphate. However, we found
that the free orthophosphate concentration in this preparation
of YP medium is only 0.7 mM using the ammonium molyb-
date/ascorbate assay (55), indicating that free phosphate levels
are low. The selectively positive effect that addition of inorganic
phosphate has on the glx3-1/glx3-1mutant in glycerol sug-
gests that supplemental orthophosphate decreasesMG levels in
the cell, possibly by favoringmore rapid catabolism of the triose
phosphates that generate MG.
DISCUSSION
Functionally diverse members of the DJ-1 superfamily are
found throughout the evolutionary tree (52, 56), and this diver-
sity allows us to take a comparative approach by examining the
enzymatic and physiological functions of these proteins in the
lower eukaryotes. The proteins of interest in this study belong
to the Hsp31 clade of the DJ-1 superfamily, which is well rep-
resented in bacteria and lower eukaryotes but largely absent in
plants and animals (52, 56). Among the fungi,C. albicans, a well
studied human pathogen (57), has only one Hsp31 homolog
(ORF 19.251), whereas the model yeast S. cerevisiae has four as
follows: YDR533C (also called Hsp31) along with the three
additional proteins YPL280W(Hsp32), YOR391C (Hsp33), and
YMR322C (SNO4). The latter three proteins are 69% identical
at the amino acid level to YDR533C and99% identical to each
other (20). In S. cerevisiae, Hsp31 has been knocked out, and the
mutant is viable butwith increased sensitivity to some oxidative
stressors (19). E. coliHsp31, a chaperone and the charter mem-
ber of this clade, is 23% identical to YDR533C from S. cerevisiae
and 22% identical to ORF 19.251 from C. albicans. Because
E. coli Hsp31 was recently shown to have a glutathione-inde-
pendent glyoxalase activity (16), we sought to determine
whether this enzymatic activity was conserved and physiologi-
cally relevant in the eukaryotic members of the Hsp31 clade of
the DJ-1 superfamily. The results of this work indicate that
fungal Hsp31-like proteins are robust glyoxalases with physio-
logically relevant roles in detoxifying endogenously produced
MG, particularly when glycerol is the principal carbon source.
Mechanism of the Glutathione-independent Glyoxalases—
The Hsp31-like glutathione-independent glyoxalases possess a
Glu-His-Cys catalytic triad, where the cysteine is highly con-
served among nearly all DJ-1 superfamily members and is cat-
alytically essential in diverse enzymes in the superfamily (58).
From a mechanistic standpoint, the conserved cysteine in the
glutathione-independent glyoxalase substitutes for the thiol of
glutathione in glyoxalase I, producing a glyoxal-derived thiohemi-
acetal in Glx3 that obviates the need for glutathione and
accounts for the absolute requirement for this conserved
cysteine for glyoxalase III activity (16). Moreover, Glx3
enzymes use no cofactor to convert methylglyoxal to lactate,
and the catalyzed reaction does not involve a redox component.
These constraints are factored into a proposed general mecha-
nism (Fig. 9) that is based on the currently acceptedmechanism
for glyoxalase I and a prior proposal for E. coli Hsp31 (16). In
this mechanism, the conserved cysteine residue (Cys136 in
Glx3) acts as the catalytic nucleophile, and a general base
abstracts a proton from the first tetrahedral thiohemiacetal
intermediate to form an enediolate intermediate. This enedio-
late intermediate was first proposed in the reactionmechanism
of glyoxalase I (lactoylglutathione lyase) (59, 60) and facilitates
the critical C1-C2 proton shift that is, in effect, a keto-enol
tautomerization. Subedi et al. (16) proposed an enediolate
intermediate for the glutathione-independent E. coli glyoxalase
III, andmore recently, Kwon et al. (61) have proposed an essen-
tially identical mechanism for the more distantly related DJ-1
superfamily glutathione-independent glyoxalases from Arabi-
dopsis thaliana. Therefore, we suggest that this may be a
FIGURE 8. Inorganic phosphate increases cell yields for the glx3 null
mutant in glycerol. In all panels, cell yields for parental cells in the absence
(filled circles) or presence (filled squares) of 10mMphosphate are shown, as are
glx3nullmutants in theabsence (open circles) or presence (open squares) of 10
mM supplemental phosphate.C. albicansweremeasuredbyoptical density in
multiple media and plotted on semi-log axes as a function of time. A shows
that added phosphate has little effect on eitherwild-type ormutant grown in
yeast extract/peptone (YP) medium. B, growth defect of the glx3 null cells
(glx3; open circles) in YPD (YP  2% glucose) medium is only slightly
improved by adding additional phosphate, and there is no effect on thewild-
type cells.C shows that the stronggrowthdefect ofglx3null cells (glx3;open
circles) in YPG (YP 2% glycerol) medium is significantly complemented by
supplementationwith inorganicphosphate. There is noeffect of addedphos-
phate on the yield of the wild-type cells in any condition. Values shown are
the average of triplicate experiments S.D.
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general mechanism for glutathione-independent glyoxalases,
even those with significantly different structures. Unresolved
aspects of the mechanism, however, are the identities of the
general bases/acids involved. Previous work (16) and our struc-
tural and mutagenesis data suggest that the conserved residues
Glu28,His106, andHis137 are viable general acid/base candidates
that deserve further scrutiny.
Close Homologs of Human DJ-1 Are Weaker Glyoxalases of
Unclear Physiological Significance—A recent report indicates
that human DJ-1 and its close homologs, Caenorhabditis
elegans DJR-1.1 and DJR-1.2, also possess glyoxalase activity
(62). This result is somewhat surprising, because these proteins
are members of a distinct clade of the DJ-1 superfamily and
possess active sites and dimeric structures that are substantially
different from theHsp31-like proteins. In particular, there is no
histidine residue in human DJ-1, DJR-1.1, or DJR-1.2 that is
structurally equivalent to the important His137 residue in
CaGlx3. As expected from these major structural differences,
we detect only weak methylglyoxalase activity for human DJ-1,
although we find somewhat higher activity for its Sz. pombe
homolog SPAC22E12.03c. We could not detect production of
the expected product D-lactate by either protein. This could be
because these enzymes generate L-lactate or some other
product or that our assay is insufficiently sensitive to detect
the small amounts of D-lactate produced by these less active
DJ-1 homologs.
There are two methodological differences that may account
for the discrepancies between our observations and previously
reported results. First, we used onlyMG as a substrate, whereas
Lee et al. (62) also used glyoxal, which appears to be a superior
substrate for some of the DJ-1 proteins. Second, we performed
our assays at 30 and 37 °C, which are standard physiological
temperatures forC. albicans, whereas Lee et al. (62) performed
their in vitro assays at 45 °C. We note, however, that Lee et al.
(62) were also able to detect glutathione-independent glyox-
alase activity in mouse and worm extracts at 22 and 37 °C but
not in extracts prepared from DJ-1 knockouts (62). Although
the specific reason for these differences is unclear, our results
indicate that Hsp31-like proteins are considerably more active
methylglyoxalases than human DJ-1. This conclusion is con-
sistentwith a recent report on the glyoxalase activities of several
A. thalianamembers of the DJ-1 superfamily, which found that
the closest homologs of humanDJ-1 in that organism (AtDJ-1A
and AtDJ-1B) have only modest glyoxalase activity (61). There-
fore, it remains to be established if the glyoxalase activities of
humanDJ-1 and its close homologs are physiologically relevant.
In contrast, the glyoxalase activities of theHsp31-likemembers
of the DJ-1 superfamily are of clear physiological significance.
Functions of Hsp31-likeGlx3 Proteins in Yeasts—Apersistent
question about MG metabolism is what, if any, purpose does
this compound serve in the cell? In bacteria, one answer to this
question is the MG bypass, which directs carbon flux from
DHAP to pyruvate through MG and D-lactate intermediates
and thus avoids the phosphate-intensive synthesis of 1,3-bis-
phosphoglycerate under phosphate-limiting conditions. In
many eukaryotes, MG production from triose phosphates is
primarily nonenzymatic, and thus no dedicated MG bypass
exists. Therefore, eukaryotic glyoxalases may serve simply to
detoxify MG that is unintentionally produced by metabolism.
However, these glyoxalases may also serve a role in eukaryotes
as a metabolic “spillway” for triose phosphate pools that accu-
mulate under nonoptimal growth conditions, including when
using glycerol as a primary carbon source. This MG spillway
serves two ends. First, it can produce pyruvate from triose phos-
phates in a GAPDH-independent pathway that includes D-lac-
tate dehydrogenase. Second, it ensures flux through glycolysis
by preventing the inhibitory accumulation of large pools of tri-
ose phosphates. The accumulation of triose phosphates is a
particular risk in inorganic phosphate-limited conditions
where GAPDH activity (which requires inorganic phosphate as
a substrate) may be compromised. Because this alternative
pathway also sacrifices all of the ATP-synthesizing steps of gly-
colysis, it can only provide an energetic benefit for yeast grow-
ing aerobically, as MG-derived pyruvate can only feed into the
TCA cycle and produce NADH to drive oxidative phosphoryl-
ation in the presence of oxygen. Therefore, in order for cells to
use the EMP pathway, they must have evolved a way to address
two related issues: avoiding the large scale accumulation of
inhibitory triose phosphates and detoxifying the low levels of
MG that arise even if the carbon flux and phosphate availabil-
ity are sufficient to keep the triose phosphate levels low.
These evolutionary constraints are both satisfied by glyox-
alases such as Glx3, possibly accounting for its wide distri-
bution and high degree of conservation in lower eukaryotes.
In this study, we have shown that the glutathione-indepen-
dent glyoxalase Glx3 is an important component of central
metabolism in C. albicans, especially when glycerol is the pri-
mary carbon source.C. albicans is particularlywell suited to the
study of endogenously producedMGbecause it does not switch
between respiratory and fermentative growth in aerobic atmo-
sphere as a function of carbon source (i.e. it is a Crabtree nega-
tive yeast).C. albicans also contains the glutathione-dependent
Glo1/Glo2 glyoxalase system, and therefore we conclude that
the glutathione-independentGlx3 enzyme studied here is func-
tionally distinct and provides a growth advantage even when
the Glo1/Glo2 system is functional. This is somewhat surpris-
ing, given that Glx3 is a significantly less efficient enzyme
(kcat/Km 1.4 103 M1 s1) than is Glo1 (kcat/Km 1.2 107
M1 s1) (63). However, unlike Glx3, Glo1 also requires
reduced glutathione as a co-substrate and has complex kinetics
FIGURE 9. Proposed enzymatic mechanism for Glx3. Electron flow is indi-
cated with arrows, and the mechanism proceeds through the numbered
steps. The proposed general acid (HA) and general base (B) are not yet iden-
tified, although His137 and Glu28 are reasonable candidates.
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as a result (64). Therefore, the in vivo rates ofMGdetoxification
by Glo1 and Glx3 may be less divergent than suggested by their
differing catalytic efficiencies. Furthermore, Glx3 activity
would be particularly valuable to the cell in conditions where
the Glo1/Glo2 system is less effective due to diminished levels
of reduced glutathione, such as chronic oxidative stress, sta-
tionary phase, or sulfur limitation. Importantly, the physiolog-
ical relevance of Glx3 activity was directly demonstrated by the
3–5-fold elevation of intracellular MG levels in glx3 knock-out
cells grown in YPD and YPG media compared with wild-type
cells, confirming that Glx3 detoxifies MG in vivo.
As glycerol catabolism produces high levels of triose phos-
phates (54), our observation that growth of the glx3 nullmutant
is strongly impairedwhen glycerol is the primary carbon source
is consistent with a spillway hypothesis for MG and Glx3 activ-
ity. This hypothesis was confirmed by the marked elevation in
the intracellular MG level measured in glx3 knock-out cells
grown in YPG media compared with those grown in YPD.
These MG levels, which are higher than any other measured
level in our experiments, are responsible for the strong growth
defect in YPGmedia because both phenomena can be comple-
mented by restoration of the wild-type GLX3 gene. Addition-
ally, our observation that supplemental inorganic phosphate
partially complements the growth defect of the glx3nullmutant
only in glycerolmedium suggests that accumulated triose phos-
phates generated by glycerol catabolism create ametabolic bot-
tleneck that phosphate supplementation helps mitigate. A
reduction in the steady-state triose phosphate pools would
decrease the level of endogenously produced MG and increase
viability for the Glx3 null cells, consistent with our observa-
tions. Finally, a role for Glx3 in both MG detoxification and as
an auxiliary part of glycolysis is also consistent with the obser-
vation that Glx3 is up-regulated 6-fold when C. albicans is
grown under hypoxic conditions. Synnott et al. (65) compared
C. albicans cultures grown in YPD with 21% oxygen versus 1%
oxygen and found increased expression for genes associated
with glycolysis and ergosterol synthesis. At that time (65),
CaGlx3 (ORF 19.251) was listed under “miscellaneous.” Recog-
nition that ORF 19.251 has glyoxalase activity means that it too
fits nicely under the hypoxia-regulated glycolysis umbrella.
Several proteins in the DJ-1 superfamily are noted for having
multiple physiological functions, and it is possible that the glx3
null mutant will exhibit multiple phenotypes upon further
study. The S. cerevisiae protein YDR533C, an exemplar of the
eukaryotic members of this clade, suggests that multiple func-
tions are plausible for many of the yeast Hsp31-like proteins.
The transcription of YDR533C is up-regulated 10–30-fold dur-
ing entry into stationary phase by hydrogen peroxide or
diamide stress, by heat stress, and by growth in the presence of
the proline analog azetidine-2-carboxylic acid, indicating that it
plays an important role in oxidative and protein unfolding
stress responses (20). Consistent with this hypothesis, a recent
study showed that YDR533C mitigates oxidative stress in S.
cerevisiae (19). Therefore, our future studies will examine the
expression of GLX3 and Glx3p in wild-type C. albicans under
stress conditions in conjunctionwith the stress responses of the
glx3 null mutant.
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